These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28235211)

  • 41. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
    Maxwell JC; Rutkowski BA
    Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Information from your family doctor. Meth abuse: what you should know.
    American Academy of Family Physicians
    Am Fam Physician; 2007 Oct; 76(8):1175-6. PubMed ID: 17990841
    [No Abstract]   [Full Text] [Related]  

  • 44. Improving Rehabilitative Care of Methamphetamine Users in Germany: The Expert's Perspective.
    Hoffmann L; Buchenauer L; Schumann N; Schröder SL; Martin O; Richter M
    Qual Health Res; 2019 Jan; 29(2):248-259. PubMed ID: 30129874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Methamphetamine Use in Central Germany: A Qualitative Study on Consumer Groups and Motives from the Experts' Perspective].
    Hoffmann L; Schumann N; Richter M
    Psychother Psychosom Med Psychol; 2018 Aug; 68(8):329-336. PubMed ID: 28895615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methamphetamine and meth mouth: an overview.
    Williams N; Covington JS
    J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
    [No Abstract]   [Full Text] [Related]  

  • 47. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contingency management: an evidence-based component of methamphetamine use disorder treatments.
    Roll JM
    Addiction; 2007 Apr; 102 Suppl 1():114-20. PubMed ID: 17493060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initiation into methamphetamine use: qualitative findings from an exploration of first time use among a group of New Zealand users.
    Sheridan J; Butler R; Wheeler A
    J Psychoactive Drugs; 2009 Mar; 41(1):11-7. PubMed ID: 19455905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methamphetamine use in patients presenting to emergency departments and psychiatric inpatient facilities: what are the service implications?
    Unadkat A; Subasinghe S; Harvey RJ; Castle DJ
    Australas Psychiatry; 2019 Feb; 27(1):14-17. PubMed ID: 30382752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The scourge of methamphetamine.
    Thomas SP
    Issues Ment Health Nurs; 2009 Aug; 30(8):473. PubMed ID: 19591019
    [No Abstract]   [Full Text] [Related]  

  • 53. METHAMPHETAMINE: WHERE WILL THE STAMPEDE TAKE US?
    Sullivan D; McDonough Michael
    J Law Med; 2015 Sep; 23(1):41-9. PubMed ID: 26554196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran.
    Shariatirad S; Maarefvand M; Ekhtiari H
    Int J Drug Policy; 2013 Nov; 24(6):e115-6. PubMed ID: 23773684
    [No Abstract]   [Full Text] [Related]  

  • 55. Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy.
    Shoptaw S; Reback CJ
    J Urban Health; 2006 Nov; 83(6):1151-7. PubMed ID: 17111217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The rise in treatment admissions for methamphetamine use in Los Angeles County from 2001 through 2005.
    Crèvecoeur D; Rutkowski B; Rawson RA
    J Psychoactive Drugs; 2007 Nov; Suppl 4():383-92. PubMed ID: 18284104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual epidemics of syphilis and methamphetamine use among drug users in Shandong Province of China.
    Liao M; Kang D; Tao X; Li J; Qian Y; Wang G; Jiang B; Bi Z; Jia Y
    AIDS Care; 2013; 25(10):1236-44. PubMed ID: 23394142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methamphetamine use in Dayton, Ohio: preliminary findings from the Ohio Substance Abuse Monitoring Network.
    Daniulaityte R; Carlson RG; Kenne DR
    J Psychoactive Drugs; 2007 Sep; 39(3):211-21. PubMed ID: 18159774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.